Corvia Medical Inc. said it obtained FDA approval of an IDE for its Interatrial shunt device (IASD) designed to treat diastolic heart failure. The Tewksbury, Mass.-based company also said it has entered into an exclusive option-to-purchase agreement with an undisclosed strategic partner.